SECURITIES AND EXCHANGE COMMISSION  
Washington, D.C. 20549  
   
SCHEDULE 13D
 
Under the Securities Exchange Act of 1934*
 

ABB Ltd

(Name of Issuer)
 

Registered Shares, par value CHF 1.03

(Title of Class of Securities)
 

ISIN No. CH0012221716**

(CUSIP Number)
 

Cevian Capital II GP Limited

La Motte Chambers

St Helier

Jersey, JE1 1BJ

Channel Islands

Attention: Denzil Boschat

+44 1534 828 513

 

with a copy to:

 

Schulte Roth & Zabel LLP

919 Third Avenue

New York, NY 10022

Attention: Eleazer N. Klein, Esq.

(212) 756-2000

(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
 

June 17, 2015

(Date of Event Which Requires Filing of This Statement)

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g), check the following box. [ ]

(Page 1 of 9 Pages)

______________________________

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

  

** The Registered Shares have no CUSIP number. The ISIN number for the Registered Shares is CH0012221716.

  

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 
ISIN No. CH0012221716SCHEDULE 13DPage 2 of 9 Pages

 

1

NAME OF REPORTING PERSON

Cevian Capital II GP Limited

2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP

(a) ¨

(b) ý

3 SEC USE ONLY
4

SOURCE OF FUNDS

AF

5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDING IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) ¨
6

CITIZENSHIP OR PLACE OF ORGANIZATION

Jersey

NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
7

SOLE VOTING POWER

118,047,114

8

SHARED VOTING POWER

-0-

9

SOLE DISPOSITIVE POWER

118,047,114

10

SHARED DISPOSITIVE POWER

-0-

11

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH PERSON

118,047,114

12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES ¨
13

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

5.3%

14

TYPE OF REPORTING PERSON

IA, OO

         

 

 
ISIN No. CH0012221716SCHEDULE 13DPage 3 of 9 Pages

 

Item 1. SECURITY AND ISSUER
   
  This statement on Schedule 13D (the "Schedule 13D") relates to the Registered Shares, par value CHF 1.03 (the "Registered Shares") of ABB Ltd, a limited liability company incorporated under the laws of Switzerland (the "Issuer"). The principal executive offices of the Issuer are located at Affolternstrasse 44, CH-8050, Zurich, Switzerland.  

 

Item 2. IDENTITY AND BACKGROUND
   
(a) This Schedule 13D is filed by Cevian Capital II GP Limited, a limited company incorporated under the laws of Jersey (the "Reporting Person"), the general partner of Cevian Capital II Master Fund LP, a Cayman Islands limited partnership (the "Master Fund") and Cevian Capital II Co-Investment Fund LP, a Cayman Islands limited partnership (the "Co-Investment Fund" and together with the Master Fund, the "Cevian Funds"), with respect to the Registered Shares held by the Cevian Funds.  
   
  The filing of this statement should not be construed as an admission that the Reporting Person is, for the purposes of Section 13 of the Securities Exchange Act of 1934, as amended, the beneficial owner of the Registered Shares reported herein.
   
(b) The principal business address of the Reporting Person is 4 Bond Street, St Helier, Jersey, JE4 5QR, Channel Islands.
   
(c) The principal business of the Reporting Person is to serve as the sole general partner and to act as investment manager to each of the Cevian Funds.
   
(d) The Reporting Person has not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).
   
(e) The Reporting Person has not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was, or is subject to, a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
   
(f) The Reporting Person is a limited company organized under the laws of Jersey.
   
  Schedule A attached hereto sets forth the information required by Instruction C of the instructions to Schedule 13D.  

 

 
ISIN No. CH0012221716SCHEDULE 13DPage 4 of 9 Pages

 


Item 3.
SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
   
  As of the date hereof, the Reporting Person has purchased for the accounts of the Cevian Funds an aggregate of 118,047,114 Registered Shares for an aggregate consideration (including brokerage commission) of approximately USD 2,669,103,790. The Cevian Funds funded these purchases out of their general working capital. The Registered Shares were purchased using Swiss Francs. For the purposes of this Schedule 13D, a conversion rate of USD 1.00 for each CHF 0.92 was used.

 

Item 4. PURPOSE OF TRANSACTION
   
  The Reporting Person acquired the Registered Shares to which this Schedule 13D relates for investment purposes in the ordinary course of business because they believed the Registered Shares represented an attractive investment opportunity.
   
  In pursuing such investment purposes, the Reporting Person may further purchase, hold, vote, trade, dispose, engage in hedging and in similar transactions with respect to the Registered Shares or otherwise deal in the Registered Shares or any derivative securities at times, and in such manner, as they deem advisable to benefit from changes in market prices of such Registered Shares, changes in the Issuer's operations, business strategy or prospects, or from sale or merger of the Issuer.  To evaluate such alternatives, the Reporting Person will routinely monitor the Issuer's operations, prospects, business development, management, competitive and strategic matters, capital structure, and prevailing market conditions, as well as alternative investment opportunities, liquidity requirements of the Reporting Person and other investment considerations.  Consistent with its investment research methods and evaluation criteria, the Reporting Person may discuss such matters with management or directors of the Issuer, other shareholders, industry analysts, existing or potential strategic partners or competitors, investment and financing professionals, sources of credit and other investors.  Such factors and discussions may materially affect, and result in, the Reporting Person's modifying the Cevian Funds' ownership of Registered Shares, exchanging information with the Issuer and any of the foregoing persons pursuant to appropriate confidentiality or similar agreements, proposing changes in the Issuer's operations, governance, capitalization, use of capital, financial metrics, capital allocations, corporate structure, including acquisitions or dispositions, proposing or nominating director candidates to the Issuer’s board of directors, changing their intention with respect to any and all matters referred to in Item 4 of Schedule 13D and/or in proposing one or more of the other actions described in subsections (a) through (j) of Item 4 of Schedule 13D as the Reporting Person may deem appropriate.
   
  Except as set forth herein, the Reporting Person has no present plan or proposal that would relate to or result in any of the matters set forth in subparagraphs (a)-(j) of Item 4 of Schedule 13D.

 

 
ISIN No. CH0012221716SCHEDULE 13DPage 5 of 9 Pages

 

Item 5. INTEREST IN SECURITIES OF THE ISSUER
   
(a) See rows (11) and (13) of the cover pages to this Schedule 13D for the aggregate number of Registered Shares and percentages of the Registered Shares beneficially owned by the Reporting Person.  The percentages used in this Schedule 13D are calculated based upon 2,237,416,798 Registered Shares reported to be outstanding as of March 31, 2015 in the Issuer's Report of Foreign Private Issuer on Form 6-K filed on April 30, 2015.
   
(b) See rows (7) through (10) of the cover pages to this Schedule 13D for the number of Registered Shares as to which the Reporting Person has the sole power to vote or direct the vote and sole power to dispose or to direct the disposition.
   
(c) The transactions in the Registered Shares by the Reporting Person for the benefit of the Cevian Funds within the past sixty days, which were all in the open market, are set forth in Schedule B, and are incorporated herein by reference.  
   
(d) No person other than the Cevian Funds and the Reporting Person is known to have the right to receive, or the power to direct the receipt of dividends from, or proceeds from the sale of, such Registered Shares.
   
(e) Not applicable.

 

Item 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER
   
  To the best of the Reporting Person's knowledge, there are no contracts, arrangements, understandings or relationships (legal or otherwise) among the persons named in Item 2 hereof and between such persons and any person with respect to any securities of the Issuer, including but not limited to transfer or voting of any of the securities of the Issuer, finder's fees, joint ventures, loan or option arrangements, puts or calls, guarantees of profits, division of profits or losses, or the giving or withholding of proxies, including any securities pledged or otherwise subject to a contingency the occurrence of which would give another person voting power or investment power over such securities other than standard default and similar provisions contained in loan agreements.

 

Item 7. MATERIAL TO BE FILED AS EXHIBITS
   
  None.

 

 
ISIN No. CH0012221716SCHEDULE 13DPage 6 of 9 Pages

 

SIGNATURES

After reasonable inquiry and to the best of its knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.

Date: June 26, 2015

 

  CEVIAN CAPITAL II GP LIMITED  
   
  By: /s/ Denzil Boschat    
  Name: Denzil Boschat
  Title: Director
     
   

 

 
ISIN No. CH0012221716SCHEDULE 13DPage 7 of 9 Pages

Schedule A

GENERAL PARTNERS, CONTROL PERSONS, DIRECTORS AND EXECUTIVE OFFICERS OF CERTAIN REPORTING PERSONS

The following sets forth the name, position, address, principal occupation and citizenship of each general partner, control person, director and/or executive officer of the Reporting Person (the "Instruction C Persons"). To the best of the Reporting Person's knowledge, (i) none of the Instruction C Persons during the last five years has been convicted in a criminal proceeding (excluding traffic violations or other similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws and (ii) none of the Instruction C Persons owns any Registered Shares or is party to any contract or agreement as would require disclosure in this Schedule 13D.

 

CEVIAN CAPITAL II GP LIMITED

 

Name   Position   Citizenship   Present Principal
Occupation
  Business Address
Denzil Boschat   Director   Jersey   Cevian CCO and Cevian Jersey CEO   4 Bond Street,
St. Helier, Jersey, JE4 5QR
Laurence Cheng   Director   Canada   Chairman & CEO Capital Z Investment Partners (Hong Kong) Ltd   142 West 57th Street 3rd Floor
New York, NY 10019
Dexter Paine   Director   USA   Managing Partner – Paine & Partners LLC   461 Fifth Avenue 17th Floor
New York, NY 10017
Liam Jones   Director   Jersey   Director – RBC Fund Administration (CI) Ltd   Le Gallais Chambers, Bath Street,
St. Helier, Jersey,  JE4 8YD
Jonathan White   Director   Jersey   Lawyer – Consultant to Ogier & Elian Fiduciary Services   44 Esplanade
St Helier, Jersey, JE4 9WG
Göran Casserlöv   CFO   Sweden   Cevian CFO   4 Bond Street,
St. Helier, Jersey, JE4 5QR
 
ISIN No. CH0012221716SCHEDULE 13DPage 8 of 9 Pages

Schedule B

This Schedule sets forth information with respect to each purchase and sale of Registered Shares which were effectuated by the Reporting Person for the benefit of the Cevian Funds within the past sixty days. All transactions were effectuated in the open market through a broker.

 

CEVIAN CAPITAL II MASTER FUND LP

Trade Date Registered Shares Purchased (Sold) Price ($)*
     
April 27, 2015 1,291,718 22.64
April 28, 2015 1,748,561 22.80
April 29, 2015 2,256,692 22.85
April 30, 2015 2,316,663 22.29
May 4, 2015 1,120,427 22.27
May 5, 2015 2,038,634 21.77
May 6, 2015 2,235,091 21.56
May 7, 2015 2,109,379 21.32
May 8, 2015 2,342,367 21.95
May 11, 2015 573,467 22.24
May 12, 2015 2,273,904 21.99
May 13, 2015 1,393,775 22.12
May 15, 2015 1,838,888 22.13
May 26, 2015 2,233,527 22.38
May 27, 2015 2,233,527 22.60
May 28, 2015 2,680,233 22.66
May 29, 2015 5,449,806 22.50
June 1, 2015 3,698,721 22.35
June 2, 2015 3,091,202 22.43
June 3, 2015 1,947,984 22.67
June 4, 2015 2,596,792 22.79
June 5, 2015 1,210,336 23.32
June 8, 2015 1,998,885 23.15
June 9, 2015 2,597,640 23.00
June 10, 2015 1,412,395 23.19
June 11, 2015 2,739,029 23.14
June 12, 2015 2,336,906 23.08
June 15, 2015 1,742,151 22.83
June 16, 2015 2,010,174 22.86
June 17, 2015 2,001,240 22.95
June 19, 2015 1,608,140 22.53
June 22, 2015 2,287,132 22.58

 

 
ISIN No. CH0012221716SCHEDULE 13DPage 9 of 9 Pages

CEVIAN CAPITAL II CO-INVESTMENT FUND LP

 

Trade Date Registered Shares Purchased (Sold) Price ($)*
     
April 27, 2015 154,109 22.64
April 28, 2015 208,614 22.80
April 29, 2015 269,237 22.85
April 30, 2015 276,392 22.29
May 4, 2015 133,673 22.27
May 5, 2015 243,221 21.77
May 6, 2015 266,659 21.56
May 7, 2015 251,661 21.32
May 8, 2015 279,458 21.95
May 11, 2015 68,418 22.24
May 12, 2015 271,290 21.99
May 13, 2015 166,286 22.12
May 15, 2015 219,390 22.13
May 26, 2015 266,473 22.38
May 27, 2015 266,473 22.60
May 28, 2015 319,767 22.66
May 29, 2015 650,194 22.50
June 1, 2015 441,279 22.35
June 2, 2015 368,798 22.43
June 3, 2015 232,406 22.67
June 4, 2015 309,812 22.79
June 5, 2015 144,400 23.32
June 8, 2015 238,479 23.15
June 9, 2015 309,914 23.00
June 10, 2015 168,507 23.19
June 11, 2015 326,782 23.14
June 12, 2015 278,807 23.08
June 15, 2015 207,849 22.83
June 16, 2015 239,826 22.86
June 17, 2015 238,760 22.95
June 19, 2015 191,860 22.53
June 22, 2015 272,868 22.58

 

* Excluding commissions, SEC fees, etc. (rounded to nearest cents). The Registered Shares were purchased using Swiss Francs. For the purposes of this Schedule 13D, a conversion rate of USD1.00 for each CHF 0.92 was used.